Nisa Investment Advisors
PMVP icon

Nisa Investment Advisors’s PMV Pharmaceuticals PMVP Stock Holding History

Nisa Investment Advisors’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-105
Closed -$159 – 3046
2024
Q4 		$159 Hold
105
– – ﹤0.01% 2959
2024
Q3 		$156 Buy
105
+40
+62% +$62 ﹤0.01% 2879
2024
Q2 		$105 Buy
+65
New +$117 ﹤0.01% 2877
2023
Q4 		– Sell
-3,485
Closed -$21.4K – 2723
2023
Q3 		$21.4K Hold
3,485
– – ﹤0.01% 1998
2023
Q2 		$21.8K Buy
+3,485
New +$18.3K ﹤0.01% 2065
2022
Q2 		– Sell
-1,200
Closed -$25K – 2480
2022
Q1 		$25K Buy
+1,200
New +$21.2K ﹤0.01% 2013

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nisa Investment Advisors's PMVP Position: Q1 2025 in Review

Nisa Investment Advisors sold out of PMV Pharmaceuticals (PMVP) in Q1 2025, closing a stake of 105 shares — an estimated $159 sold.

Nisa Investment Advisors first reported a position in PMVP in Q1 2022 and held it in 6 quarters. The position peaked at $25K in Q1 2022. 55 funds tracked by Wall St. Rank hold PMVP as of Q1 2025.

  • Nisa Investment Advisors reported no remaining PMV Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 105 PMV Pharmaceuticals shares in Q1 2025, an estimated $159.
  • Nisa Investment Advisors first reported a position in PMV Pharmaceuticals in Q1 2022 and held it in 6 quarters.
  • Nisa Investment Advisors's PMV Pharmaceuticals position peaked at $25K in Q1 2022.
  • 55 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2025.

Based on Nisa Investment Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.